BackAVEO Pharmaceuticals Overview

AVEO Pharmaceuticals Selling, General & Admin

AVEO Pharmaceuticals selling, general & admin — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$17.58M
16.09% YoY

As of Sep 30, 2022

Annual SG&A Expenses (TTM)

$67.64M
24.87% YoY

Trailing 12 months ending Sep 30, 2022

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

AVEO Pharmaceuticals (AVEO) FAQ

Stockcircle tracks selling, general & admin for AVEO Pharmaceuticals (AVEO), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for AVEO Pharmaceuticals's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main AVEO overview so you can move from this figure to the surrounding analysis quickly.